NCT00293787 - A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution

Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

OTHER

Timolol Vehicle

Placebo

DRUG

Latanoprost 0.005% Ophthalmic Solution (XALATAN)

Commercially marketed ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension

DRUG

Timolol Maleate Ophthalmic Solution 0.5%

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension